Literature DB >> 11257470

Abnormalities in the expression of nebulin in chromosome-2 linked nemaline myopathy.

C A Sewry1, S C Brown, K Pelin, H Jungbluth, C Wallgren-Pettersson, S Labeit, A Manzur, F Muntoni.   

Abstract

Nemaline myopathy is clinically and genetically heterogeneous. The most common autosomal recessive form affecting infants (NEM2) links to chromosome 2q, and is caused by mutations in the gene for nebulin. We have examined the immunocytochemical expression of nebulin in skeletal muscle in 11 cases of nemaline myopathy, from ten families, with linkage compatible to chromosome 2q.22, the locus for nebulin. Mutations in the gene for nebulin have been found in eight of these cases. Immunolabelling with polyclonal antibodies to C-terminal regions of nebulin was compared with antibodies to fibre-type-specific myofibrillar proteins, including myosin heavy chain isoforms and alpha-actinin isoforms. No cases showed a complete absence of C-terminal nebulin, and no enhancement of labelling of the rods was seen with conventional fluorescence microscopy. In control muscle an antibody to the M176-181 repeat region of nebulin showed higher expression in fibres with slow myosin, while ones to the serine-rich domain and to the SH3 domain showed uniform expression. In some cases of nemaline myopathy differences in these patterns were observed. Two siblings with a homozygous mutation in exon 185, that produces a stop codon, showed an absence of labelling only with the SH3 antibody, and other cases showed uneven labelling with this antibody or some fibres devoid of label. Fibre type correlations also showed differences from controls, as some fibres had a fast isoform of one protein but a slow isoform of another. These results indicate that analysis of nebulin expression may detect abnormalities in some cases linked to the corresponding locus and may help to direct molecular analysis. In addition, they may also be relevant to studies of fibre type plasticity and diversity in nemaline myopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257470     DOI: 10.1016/s0960-8966(00)00172-3

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

1.  Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene.

Authors:  Sylvia L Anderson; Josef Ekstein; Mary C Donnelly; Erin M Keefe; Nicole R Toto; Lauretta A LeVoci; Berish Y Rubin
Journal:  Hum Genet       Date:  2004-06-23       Impact factor: 4.132

Review 2.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2).

Authors:  Coen A C Ottenheijm; Pleuni Hooijman; Elizabeth T DeChene; Ger J Stienen; Alan H Beggs; Henk Granzier
Journal:  J Struct Biol       Date:  2009-11-26       Impact factor: 2.867

4.  Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency.

Authors:  Coen A C Ottenheijm; Christian C Witt; Ger J Stienen; Siegfried Labeit; Alan H Beggs; Henk Granzier
Journal:  Hum Mol Genet       Date:  2009-04-04       Impact factor: 6.150

5.  Nebulin alters cross-bridge cycling kinetics and increases thin filament activation: a novel mechanism for increasing tension and reducing tension cost.

Authors:  Murali Chandra; Ranganath Mamidi; Steven Ford; Carlos Hidalgo; Christian Witt; Coen Ottenheijm; Siegfried Labeit; Henk Granzier
Journal:  J Biol Chem       Date:  2009-09-07       Impact factor: 5.157

6.  Mutation update: the spectra of nebulin variants and associated myopathies.

Authors:  Vilma-Lotta Lehtokari; Kirsi Kiiski; Sarah A Sandaradura; Jocelyn Laporte; Pauliina Repo; Jennifer A Frey; Kati Donner; Minttu Marttila; Carol Saunders; Peter G Barth; Johan T den Dunnen; Alan H Beggs; Nigel F Clarke; Kathryn N North; Nigel G Laing; Norma B Romero; Thomas L Winder; Katarina Pelin; Carina Wallgren-Pettersson
Journal:  Hum Mutat       Date:  2014-12       Impact factor: 4.878

7.  Novel mutations in NEB cause abnormal nebulin expression and markedly impaired muscle force generation in severe nemaline myopathy.

Authors:  Michael W Lawlor; Coen A Ottenheijm; Vilma-Lotta Lehtokari; Kiyomi Cho; Katarina Pelin; Carina Wallgren-Pettersson; Henk Granzier; Alan H Beggs
Journal:  Skelet Muscle       Date:  2011-06-20       Impact factor: 4.912

Review 8.  Nemaline myopathies: a current view.

Authors:  Caroline A Sewry; Jenni M Laitila; Carina Wallgren-Pettersson
Journal:  J Muscle Res Cell Motil       Date:  2019-06-21       Impact factor: 2.698

9.  Two alternatively-spliced human nebulin isoforms with either exon 143 or exon 144 and their developmental regulation.

Authors:  Le Thanh Lam; Ian Holt; Jenni Laitila; Mubashir Hanif; Katarina Pelin; Carina Wallgren-Pettersson; Caroline A Sewry; Glenn E Morris
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.